Phytochemical and Pharmacological Properties of<i> Chaenomeles speciosa</i>: An Edible Medicinal Chinese Mugua

Huang, Weifeng; He, Junwei; Nisar, Muhammad Farrukh; Li, Hongshui; Wan, Chunpeng

doi:https://doi.org/10.1155/2018/9591845

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Conclusions Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2018 | Article ID 9591845 | https://doi.org/10.1155/2018/9591845

Phytochemical and Pharmacological Properties of Chaenomeles speciosa: An Edible Medicinal Chinese Mugua

Weifeng Huang,¹Junwei He,²Muhammad Farrukh Nisar,³Hongshui Li,⁴and Chunpeng Wan⁵

Academic Editor: Wen-yi Kang

Received07 Nov 2018

Revised26 Nov 2018

Accepted03 Dec 2018

Published09 Dec 2018

Abstract

Chaenomeles plants are adapted to diverse ecological zones particularly the temperate areas of Korea, Japan, and China. In China, Chaenomeles speciosa is mainly planted in Chongqing, Anhui, and Hubei provinces. Most of the studies till date have been focused on the anti-inflammatory activities of C. speciosa fractions. The present study aimed to review the maximum literature reported for the presence of various phytochemicals in C. speciosa. In addition, the pharmacological properties of these chemical compounds of this plant shall also be discussed. The extracts of the various parts of the plant are rich in diversity of antioxidants, organic acids, phenolics, terpenoids, and many different phytochemicals that bear strong anticancer, antioxidant, antiviral, antibacterial properties, anti-inflammation, antihyperlipidemic, antihyperglycemic, and anti-Parkinson properties. C. speciosa fruits have broad scope in industry as well as in medicines. Not only the leaves and fruits of C. speciosa plant, but various other parts including roots, seeds, bark twigs, and flowers all have long history of clinical trials in curing many human ailments. However, the maximum accessible data concerning the chemical compositions and their broad pharmacological properties of C. speciosa plant parts is pretty restricted that make it more appealing for in-depth investigations.

1. Introduction

Chaenomeles plants are adapted to diverse ecological zones, but mostly occupied the temperate areas of Korea, Japan, and China. In China, it is mainly planted in Chongqing, Anhui, and Hubei provinces and locally called ‘Zhoupi mugua’, which has been well documented in broad traditional Chinese herbal medication systems. Recent scientific studies unveil high nutritional value of this plant. In the past few decades, cultivation of C. speciosa became a part of routine agriculture and fulfilling an ever increasing demands of the industry particularly the fruits juices, fruits tea, vinegar and fruit preservation, etc. Many of the agriculture varieties have been introduced in the market, to increase the gross yield of which three traditional varieties are well known, i.e., Luohanji, Zimugua, and Changjun [1]. The extracts of the fruits of C. speciosa are rich in diverse antioxidants and many different phytochemicals that bear strong anticancer, antioxidant, antiviral, antibacterial properties, anti-inflammation, antihyperlipidemic, antihyperglycemic, and anti-Parkinson properties [2–6].

Chaenomeles are enriched with antioxidants and α-glucosidase inhibitory activities are well documented in recent studies [7]. Various parts of the Chaenomeles plant which have variable amounts of phytochemicals such as peels are rich in triterpenes, due to which it is highly antioxidant [7]. This is quiet common observation which is being supported by multiple studies, that peels of a variety of fruits such as pear and hawthorn are having more antioxidants [8]. In case of Chaenomeles most of its peels are being wasted and ultimately huge amount of good source of antioxidants is gone wasted [8]; hence Chaenomeles is a potential candidate in terms of superior performance due to its higher α-glucosidase and antioxidant functions [7]. In addition to these, various triterpenes and phenolics are also present in the plant extracts, especially ursolic and oleanolic acids which are potential chemicals being recognized even in People’s Republic of China Pharmacopoeia. Moreover, various minor but active compounds, namely, chlorogenic acid, catechin, epicatechin, gallic acid, protocatechuic acid, caffeic acid, and syringic acid have also been isolated from Chaenomeles [9, 10]. C. speciosa fruits are well studied for their ingredients and phytochemical compounds such as polyphenols and vitamin C [11], and studies depicted that it could be a good source for the natural antioxidants and sufficient amount of fibers and low amount of citric acid [11, 12].

C. speciosa is a member of family Rosaceae, and also known as flowering quince [13]. Traditionally, C. speciosa has widely been used in clinical trials to treat hepatitis, rheumatoid arthritis, and prosopalgia [14]. It is also used as an edible food, canned food, preserved fruit, fruit wine, fruit vinegar, and juices [13]. Most of the studies till date have been focused on the anti-inflammatory activities of C. speciosa fractions. The present study aimed to review the maximum literature reported for the presence of phytochemicals in C. speciosa. In addition, the pharmacological properties of these chemical compounds of this Chaenomeles fruits shall also be discussed.

2. Chemical Constituents

Up to now, approximately 64 chemical constituents have been isolated and identified from C. speciosa, including triterpenes, sesquiterpenoids, flavonoids, phenylpropanoids, phenols, biphenyls, and others. Among them, triterpenes and flavonoids were considered to be the primary bioactive constituents of C. speciosa. The components isolated from C. speciosa are summarized in the current review (Figures 1–7).

2.1. Triterpenes

Triterpenes are regarded as the major bioactive ingredients of Chaenomeles species, and phytochemical studies are focusing this genus since last two decades [15]. To date, 13 steroid compounds have been isolated and identified from C. speciosa. The steroids and theirs chemical structures are well described in recent studies (Table 1 and Figure 1). They all exist in the form of aglycones that belong to pentacyclic triterpenoids, including ursanes (1-7), lupanes (8-11), and oleananes (12 and 13).

2.2. Sesquiterpenoids

Sesquiterpenoids represent a relatively small group of compounds in Chaenomeles species. To date, only five sesquiterpenoids were obtained from the ethanolic extract of C. speciosa so far. Their structures of these compounds are shown in Table 2 and Figure 2.

2.3. Flavonoids

Flavonoids are comprised of a huge number of polyphenolic compounds having a benzo-γ-pyrone organization, which is universally occurred in plant kingdom; there is no exception for Chaenomeles species. Flavonoids are the second major bioactive constituents in Chaenomeles species and they are divided into three categories including one flavone (19), three flavanonols (20–22), and five anthocyanins (23–27). Their structures of these compounds are shown in Table 3 and Figure 3.

2.4. Phenylpropanoids

Chaenomeles species are also rich in phenylpropanoids. Almost 9 phenylpropanoids were isolated and identified from C. speciosa to date. These phenylpropanoids include 8 phenylpropionic acids (28–31 and 33–36) and one phenylpropanol (32). Their structures of these compounds are elaborated in Table 4 and Figure 4.

2.5. Phenols

Many studies reported the presence of the aliphatic compounds in Chaenomeles species. Nine phenols (37–45) were isolated from C. speciosa. Their structures of these compounds are shown in Table 5 and Figure 5.

2.6. Biphenyls

To date, only five biphenyls (46–50) were obtained from the ethanolic extract of C. speciosa. Their structures of these compounds are shown in Table 6 and Figure 6.

2.7. Others

In addition to the above-mentioned main components, other components (Table 7 and Figure 7) are also found in Chaenomeles species, such as fatty acid (51–53), quinic acids (57-59), coumarin (61 and 62), and steroids (63 and 64).

3. Pharmacological Activities

Various natural compounds have served huge industrial and individual demands in curing multiple diseases due to their potential pharmacological properties. This lust gained attention of the scientists to continue exploration of such similar plants and compounds bearing similar medicinal importance. Dried Chaenomeles fruits are being used as traditional herbal medicines since centuries within mainland of China to cure dysentery, prosopalgia, rheumatoid arthritis, cholera, beriberi, vitamin C deficiency syndrome, enteritis, and hepatitis [14, 30]. Presence of complex compounds such as phenolics, tannins, multiple organic acids, glycosides, and flavones in Chaenomeles made it an important plant having diverse pharmacological properties [31, 32]. The following sections will highlight and update the various pharmacological properties of Chaenomeles plant reported in recent years. Chaenomeles plant has said to possess diverse biological functions, due to which it has been in use since centuries in traditional Chinese medicine [13, 30, 33]. Modern day research also confirmed that C. speciosa is enriched in diverse pharmacological and biological properties particularly anti-inflammation, immunomodulation, antimicrobial, antitumor, and antioxidant actions are notable [33, 34].

3.1. Antioxidant Property

The botanical extracts are a potential source of natural antioxidants with almost no side effects [13]. The extracts of C. speciosa fruits have very strong antioxidant ability. In a recent study, it was claimed that C. speciosa have a strong potential for scavenging free radicals, i.e., various reactive oxygen species (ROS) and free nitrous oxide mainly due to the presence of strong antioxidant compound quercetin [17]. In atherosclerosis, level of LDL increased with decreased antioxidant capability in the blood due to the formation of LDL-oxidation complexes [35], which was successfully treated with the application of powdered C. speciosa that was thought to be due to its higher antioxidant nature of the plant parts that increased increasing the antioxidant levels in the blood and declining the cholesterol levels [36]. Moreover, various polysaccharides are being extracted from C. speciosa and reported to possess strong antioxidant activity [37].

A huge amount of flavonoid contents reported in C. speciosa has shown significant reduction in peroxide levels in lard, removed DPPH, and deoxidized the iron (Fe³⁺) in a concentration-dependent fashion, demonstrating its strong antioxidant nature compared to ascorbic acid (vitamin C) [38]. Moreover, quercetin and 3,4-dihydroxybenzoic acid which were extracted from C. speciosa showed higher inhibition for DPPH (2,2-diphenyl-1-picrylhydrazyl) and neuraminidase [17]. The antioxidants activity in five species of Chaenomeles (Mugua) was studied and about 44 fractions were prepared that showed a potent and stable free-radical DPPH and the hydroxyl radicals scavenging activity [39].

3.2. Anti-Inflammatory and Analgesic Activities

C. speciosa plant also being administered in inflammatory and immune related issues and glucosides present in the extracts have strong anti-inflammation as well as immunoregulatory properties [34, 40]. Methyl-3-hydroxybutanedioic ester found in C. speciosa has also been reported to possess strong anti-inflammatory effects particularly in inflammatory avian influenza and dyspepsia [17]. Various plant extracts even in fractions have also been reported to possess good potential against inflammations, pains and antianalgesic activity mainly due to the presence of chlorogenic acid [13]. Some of the Chaenomeles polysaccharides also showed anti-inflammatory activities [41]. In another study, it was reported that Chaenomeles fractions control the calcium channels, due to which it has got higher analgesic activity [42]. C. speciosa plant is in use since long time to treat rheumatoid arthritis in various parts of China primarily due to its antinociceptive and anti-inflammatory potential [40]

3.3. Antiatherosclerotic Effects

As arteriosclerosis is a systemic condition, hyperlipidemias, especially oxidized low-density lipoprotein (LDL), are major elements that initiate this route and result in the formation of plaque [43]. Atherosclerosis is a condition, where the level of antioxidants decreased within the blood due to oxidation of LDL. Level of LDL increased with decreased antioxidant capability in the blood due to the formation of complexes [35], which was successfully treated by the application of powdered C. speciosa. It was thought to be due to the higher antioxidant nature of the plant parts by increasing the antioxidant levels in the blood and declining the cholesterol levels [36].

3.4. Antitumor and Immunomodulatory Activities

Cancer is the main cause of a large number of deaths across the world. Most of the cytotoxic drugs being used to cure cancer tissues have also been reported to be harmful to the normal tissues [44]. An average molecular weight water-soluble polysaccharide was successfully extracted from C. speciosa that is composed of glucose, rhamnose, galactose, and arabinose. This polysaccharide is good in inhibiting the tumor growth in the mice along with improvement in delayed type hypersensitivity and higher secretion of interleukin- (IL-) 2, TNF-α, and IFN-γ in blood serum [45]. It is further suggested that the antitumor effects of this polysaccharide might be due to the association with its potent immunostimulatory activity in vivo [45]. Many of the plant based polysaccharides are less nontoxic with hardly any serious problems compared with certain synthetic compounds and hence make these polysaccharides a superior choice for modern medication [46, 47].

It was in the mid-1970s, when it was said for the first time that various organic acids present in C. speciosa have strong antitumor activity studied on Ehrlich ascites carcinoma in mice [48], and this antitumor activity is because of the presence of multiple terpenoids [49, 50]. Among various acids present in this plant, there are betulinic, maslinic, oleanolic, and ursolic acids which are the prominent triterpenoid chemicals [51]. Oleanolic and ursolic acids in plants have inhibitory effects on estrogen receptor-negative breast cancer, osteosarcoma cells, and HuH7 human hepatocellular carcinoma cells, which induce quick apoptosis in the cancer cells [51–53]. Moreover, various acids present in the plant extracts including maslinic acids showed potential antiangiogenic properties on non-small-cell and lung cancer cells [51, 54]. In vivo, ethanolic extracts of C. speciosa checked the growth of tumors along with increased immune responses in mice, while Foxp3, TGF-β, and PD-L1 protein expression levels were reduced within the tumors [3]. It was the pioneer study that explained ethanolic extracts of C. speciosa which strongly inhibited the growth and invasion of tumors by direct killing of cancerous cells as well as enhanced immune responses [3].

3.5. Antidiarrhea

Various organic acids (betulinic, oleanolic, and ursolic acids) are the active components in fruits of C. speciosa which are regarded as potent therapeutic candidates in treating LT-induced diarrhea [55]. Moreover, studies used the extracts of C. speciosa showing strong antimicrobial activity and analgesic effects [13, 33]. It is further suggested that G-protein-AC-cAMP regulated signaling has a major role in reducing the inflammation and deterioration of joints in arthritis rats [40]. Intervention of intracellular signaling cascades in synoviocytes by using glucosides of C. speciosa may consequently suppressed the deterioration of bones and reduction of inflammations in autoimmune rat models. The major and prominent effect of C. speciosa glucosides on higher cAMP levels in synoviocytes are thought to be linked with its inhibitory protein (Gi). Moreover, this Gi-protein mediated AC-cAMP signaling cascade is thought to be one of the vital procedures in reducing inflammations and modulating-immune responses by glucosides of C. speciosa [56–58].

3.6. α-Glucosidase Inhibitory

Among many varieties being cultivated within China, C. speciosa Var. Yunnan showed maximum antioxidant potential along with α-glucosidase inhibition [59]. Moreover, another study confirmed that, in C. speciosa total amount of polysaccharides, flavonoids, ursolic acid, and polyphenols are the prominent phytochemicals bearing good antioxidant properties. In addition to it, complete polysaccharides and flavonoid contents are mainly involved in inhibition of α-glucosidase activity of C. speciosa [60]. Such studies shall be helpful in qualitative evaluation of the C. speciosa and its implementation in different industries. Moreover, peels can be a good source of inhibitors of α-glucosidase activity and antioxidants within the broad range of pharmaceutical as well as related industries [1]. Until now, many phytochemicals having strong α-glucosidase inhibition potential are under use as an oral hypoglycemic medicines to check hyperglycemia [60]. Furthermore, exploration of α-glucosidase inhibitors is of supreme priority for finding novel antidiabetic drugs [61].

3.7. Antiviral Activity

The viral particles spread and replicates within the host cells cause severe disturbances and conditions. Recently, many influenza viral epidemics have been out broken in many parts of the world. The annual report by World Health Organization (WHO) published early in 2018 explained that data from about all over the world laboratories has confirmed many incidents of epidemic influenza H1N1 2009 that caused almost 13,554 mortalities [17]. The birds influenza virus mainly generated the oxidative stress and amplify the inflammations within the patient. Quercetin, 3,4-dihydroxybenzoic acid and methyl-3-hydroxybutanedioic esters, which were extracted from C. speciosa, pose a synergistic effect during the treatment of avian influenza and hence proved as prospective and strong antiviral compounds [17]. Avian influenza is frequent and followed with virus invasion along with increased oxidative stress and heavy inflammations. Furthermore, numerous effects of the C. speciosa compounds have a potential and specialized role in curing avian influenza; particularly quercetin would be a strong anti-inflammation and antiviral compound [17]. The oleanolic acid extracted from C. speciosa (20μg/ml) robustly inhibits the replication of hepatitis B virus genome which showed a powerful inhibition ratio (29.33%) [62]. The C. speciosa plant extract contains powerful antioxidants in it that depicts it could potentially be used to cure new influenza A virus epidemics.

It is summarized that continuous research interests have explored plenty of natural compounds from C. speciosa plant. Such explorations of novel compounds from this plant have been said to possess strong medical importance. In certain disease aroused mainly of heavy oxidative stress, it is being replenished by the strong antioxidant nature of this plant. The flavonoids present in C. speciosa mainly reduce peroxide and LDL levels, remove DPPH and deoxidize free cellular iron (Fe³⁺), and hence pose a strong antioxidant effect. Moreover, C. speciosa plant also contributed its immune modulatory and anti-inflammatory effects by reducing the expression of interleukins and related inflammatory factors. The various phytochemicals particularly the polysaccharides present in C. speciosa possess α-glucosidase inhibition potential and hence reduce hypoglycemic conditions. Similarly, antimicrobial and analgesic effects of the C. speciosa compounds are mainly following G-protein-AC-cAMP regulated signaling cascade to reduce the inflammation and deterioration of joints in arthritis rats. In different virus associated pathologies such as avian influenza, quercetin, 3,4-dihydroxybenzoic acid, and methyl-3-hydroxybutanedioic esters reduce the oxidative stress and expression of many inflammatory factors caused by the viral pathogen and hence relive the pains and condition of the patient. Moreover, oleanolic acid present in C. speciosa efficiently inhibits the replication of hepatitis B virus genome.

4. Conclusions

It is concluded that C. speciosa have broad scope in industry and in medicines. Not only the leaves and fruits of C. speciosa plant, but various other parts which include roots, seeds, bark twigs, and flowers, all have long clinical trials history in curing many human ailments. However, the maximum accessible data concerning the chemical composition and their broad pharmacological properties of various parts of C. speciosa plants is quiet less that make it more appealing for in-depth investigations.

Conflicts of Interest

The authors declare no conflicts of interest.

Authors’ Contributions

Weifeng Huang and Junwei He contributed equally to this work. Chunpeng Wan and Weifeng Huang contributed to conceptualization; Chunpeng Wan contributed to investigation; Weifeng Huang, Junwei He, Muhammad Farrukh Nisar, and Hongshui Li contributed to writing and original draft preparation; Chunpeng Wan contributed to writing and review and editing; Chunpeng Wan contributed to supervision; Chunpeng Wan contributed to project administration; Weifeng Huang contributed to funding acquisition.

Acknowledgments

This research was funded by Educational Support for Poverty Alleviation from China Three Gorges University, Grant no. KJ2018QT007. We are very grateful for the assistance provided by Tingdong Yan (Duke-NUS Medical School, Singapore) in summary of pharmacological activities of C. speciosa.

References

J. Miao, X. Li, C. Zhao, X. Gao, Y. Wang, and W. Gao, “Active compounds, antioxidant activity and α-glucosidase inhibitory activity of different varieties of Chaenomeles fruits,” Food Chemistry, vol. 248, pp. 330–339, 2018.
View at: Publisher Site | Google Scholar
S. Sancheti, S. Sancheti, M. Bafna, and S.-Y. Seo, “Antihyperglycemic, antihyperlipidemic, and antioxidant effects of Chaenomeles sinensis fruit extract in streptozotocin-induced diabetic rats,” European Food Research and Technology, vol. 231, no. 3, pp. 415–421, 2010.
View at: Publisher Site | Google Scholar
G. Yao, C. Liu, H. Huo et al., “Ethanol extract of Chaenomeles speciosa Nakai induces apoptosis in cancer cells and suppresses tumor growth in mice,” Oncology Letters, vol. 6, no. 1, pp. 256–260, 2013.
View at: Publisher Site | Google Scholar
J. Miao, X. Li, C. Zhao et al., “Solvents effect on active chemicals and activities of antioxidant, anti-α-glucosidase and inhibit effect on smooth muscle contraction of isolated rat jejunum of Chaenomeles speciosa,” Journal of Functional Foods, vol. 40, pp. 146–155, 2018.
View at: Publisher Site | Google Scholar
G. Zhao, Z.-H. Jiang, X.-W. Zheng, S.-Y. Zang, and L.-H. Guo, “Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract,” Pharmacology Biochemistry & Behavior, vol. 90, no. 3, pp. 363–371, 2008.
View at: Publisher Site | Google Scholar
C. Guo, C. Tian, and S. Tang, “Clinical observation on the effect of Chaenomeles speciosa to 107 cases acute bacillary dysentery,” Chinese Medical Journal, vol. 64, pp. 689–693, 1984.
View at: Google Scholar
J. Miao, C. Zhao, X. Li et al., “Chemical Composition and Bioactivities of Two Common Chaenomeles Fruits in China: Chaenomeles speciosa and Chaenomeles sinensis,” Journal of Food Science, vol. 81, no. 8, pp. H2049–H2058, 2016.
View at: Publisher Site | Google Scholar
C. Guo, J. Yang, J. Wei, Y. Li, J. Xu, and Y. Jiang, “Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay,” Nutrition Research, vol. 23, no. 12, pp. 1719–1726, 2003.
View at: Publisher Site | Google Scholar
H. Du, J. Wua, H. Li et al., “Polyphenols and triterpenes from Chaenomeles fruits: chemical analysis and antioxidant activities assessment,” Food Chemistry, vol. 141, no. 4, pp. 4260–4268, 2013.
View at: Publisher Site | Google Scholar
RL. Chen, Wu. TJ, and YJ. Dai, “Studies on the Chemical Constiuents of Four Species of Chaenomeles,” West China Journal of Pharmaceutical Sciences, vol. 15, pp. 38-39, 2000.
View at: Google Scholar
J. Ros, J. Laencina, P. Hellin, M. JORDAN, R. Vila, and K. Rumpunen, “Characterization of juice in fruits of different Chaenomeles species,” LWT—Food Science and Technology, vol. 37, no. 3, pp. 301–307, 2004.
View at: Publisher Site | Google Scholar
M. Thomas, M. J. Crépeau, K. Rumpunen, and J.-F. Thibault, “Dietary fibre and cell-wall polysaccharides in the fruits of Japanese quince (Chaenomeles japonica),” LWT- Food Science and Technology, vol. 33, no. 2, pp. 124–131, 2000.
View at: Publisher Site | Google Scholar
X. Li, Y.-B. Yang, Q. Yang, L.-N. Sun, and W.-S. Chen, “Anti-inflammatory and analgesic activities of chaenomeles speciosa fractions in laboratory animals,” Journal of Medicinal Food, vol. 12, no. 5, pp. 1016–1022, 2009.
View at: Publisher Site | Google Scholar
S. Zhang, L. Han, H. Zhang, and H. Xin, “Chaenomeles speciosa: A review of chemistry and pharmacology,” Biomedical Reports, vol. 2, no. 1, pp. 12–18, 2014.
View at: Publisher Site | Google Scholar
X. M. Guo, Y. F. Hong, and L. Zhang, “Studies on the Chemical Constituents of Common Floweringquince (Chaenomeles lagenaria),” Chinese Traditional and Herbal Drugs, vol. 28, pp. 584-585, 1997.
View at: Google Scholar
Y.-L. Song, L. Zhang, J.-M. Gao, G.-H. Du, and Y.-X. Cheng, “Speciosaperoxide, a new triterpene acid, and other terpenoids from Chaenomeles speciosa,” Journal of Asian Natural Products Research, vol. 10, no. 3, pp. 214–217, 2008.
View at: Publisher Site | Google Scholar
L. Zhang, Y.-X. Cheng, A.-L. Liu, H.-D. Wang, Y.-L. Wang, and G.-H. Du, “Antioxidant, anti-inflammatory and anti-influenza properties of components from chaenomeles speciosa,” Molecules, vol. 15, no. 11, pp. 8507–8517, 2010.
View at: Publisher Site | Google Scholar
H. C. Chen, L. S. Ding, S. L. Peng, and X. Liao, “Study on the chemical constituents in Chaenomeles speciosa,” Chinese Traditional and Herbal Drugs, vol. 36, pp. 30-31, 2005.
View at: Google Scholar
X. M. Guo, L. Zhang, S. C. Quan, Y. F. Hong, L. N. Sun, and M. Z. Liu, “Isolation and identification of Triterpenoid compounds in the fruits of Chaenomeles lagenaria (Loisel.) Koidz,” Chinese Journal of Chinese Materia Medica, vol. 23, pp. 546-547, 1998.
View at: Google Scholar
K. Yin, H. Y. Gao, X. N. Li, and L. J. Wu, “Chemical constituents of Chaenomeles speciosa (Sweet.) Nakai,” Journal of Shenyang Pharmaceutical University, vol. 23, pp. 760–763, 2006.
View at: Google Scholar
W. S. Suh, K. J. Park, D. H. Kim et al., “A biphenyl derivative from the twigs of Chaenomeles speciosa,” Bioorganic Chemistry, vol. 72, pp. 156–160, 2017.
View at: Publisher Site | Google Scholar
M. C. Liao, S. Y. Xiong, F. Y. Yang, and L. L. Ge, “Studies on Chemical Constituents from Chaenomeles Speciosa (Sweet) Nakai's Fruits,” Journal of South-Central University for Nationalities (Nat, Sci, Edition), vol. 32, pp. 39–41, 2013.
View at: Google Scholar
G. Huang, Z. Xi, J. Li et al., “Sesquiterpenoid Glycosides from the Fruits of Chaenomeles speciosa,” Chemistry of Natural Compounds, vol. 51, no. 2, pp. 266–269, 2015.
View at: Publisher Site | Google Scholar
X. Li, Y. B. Yang, Z. X. Xi, L. Sun, W. S. Chen, and L. N. Sun, “The chemical Constituents in the n-butanol Extracts of Cheanomeles speciosa (Sweet) Nakai,” Lishizhen Med Mater Med Res, vol. 23, pp. 1670-1671, 2012.
View at: Google Scholar
Y. L. Song, Z. B. Feng, Y. X. Cheng, and J. M. Gao, “Chemical Components of Chaenomeles speciosa (Sweet) Nakai,” Acta Botanica Boreali-Occidentalia Sinica, vol. 27, pp. 831–833, 2007.
View at: Google Scholar
Y.-B. Yang, X. Li, Q. Yang, Z.-J. Wu, and L.-N. Sun, “Studies on chemical constituents of Chaenomeles speciosa (sweet) Nakai (II),” Academic Journal of Second Military Medical University (AJSMMU), vol. 30, no. 10, pp. 1195–1198, 2009.
View at: Publisher Site | Google Scholar
G.-H. Huang, Z.-X. Xi, J.-L. Li et al., “Isolation of two new phenolic compounds from the fruit of Chaenomeles speciosa (Sweet) Nakai,” Phytochemistry Letters, vol. 6, no. 4, pp. 526–530, 2013.
View at: Publisher Site | Google Scholar
C. F. Timberlake and P. Bridle, “Anthocyanins in petals of Chaenomeles speciosa,” Phytochemistry, vol. 10, no. 9, pp. 2265–2267, 1971.
View at: Publisher Site | Google Scholar
Y. B. Yang, Y. Yang, X. Li et al., “Studies on the chemical constituents of Chaenomeles speciosa,” J Chin Med Mater, vol. 32, pp. 1388–1390, 2009.
View at: Google Scholar
College JNM, Dictionary of Chinese Materia Medica, Shanghai Scientific and Technological Press, Shanghai, 1977.
D. Li and L. He, “Determination of olenolic acid and urolic acid in Fructus chaenomelis by HPLC-evaporative light-scattering detection method,” Chinese Journal of Hospital Pharmacy, vol. 25, pp. 259–261, 2005.
View at: Google Scholar
H. S. Yin, H. M. Liu, and Y. L. Liu, “Structural Characterization of lignin in fruits and stalks of Chinese Quince,” Molecules, vol. 22, p. 890, 2017.
View at: Publisher Site | Google Scholar
X. Xianfei, C. Xiaoqiang, Z. Shunying, and Z. Guolin, “Chemical composition and antimicrobial activity of essential oils of Chaenomeles speciosa from China,” Food Chemistry, vol. 100, no. 4, pp. 1312–1315, 2007.
View at: Publisher Site | Google Scholar
M. Dai, W. Wei, Y.-X. Shen, and Y.-Q. Zheng, “Glucosides of Chaenomeles speciosa remit rat adjuvant arthritis by inhibiting synoviocyte activities,” Acta Pharmacologica Sinica, vol. 24, no. 11, pp. 1161–1176, 2003.
View at: Google Scholar
L. Tamer, N. Sucu, G. Polat et al., “Decreased serum total antioxidant status and erythrocyte-reduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients,” Archives of Medical Research, vol. 33, no. 3, pp. 257–260, 2002.
View at: Publisher Site | Google Scholar
Y. Tang, X. Yu, M. Mi, J. Zhao, J. Wang, and T. Zhang, “Antioxidative property and antiatherosclerotic effects of the powder processed from chaenomeles speciosa in apoe^−/− mice,” Journal of Food Biochemistry, vol. 34, no. 3, pp. 535–548, 2010.
View at: Publisher Site | Google Scholar
J. Liu, W. Wang, K. Lu, L. Ma, and T. X. Zhang, “Extraction and antioxidation activity of polysaccharides from Chaenomeles speciosa (sweet.) nakai,” Journal of Henan University of Technology (Natural Science Edition), vol. 1, pp. 48–52, 2011.
View at: Google Scholar
Z. Liu, S. D. Hu, K. Zou, and J. R. Pan, “Studies of Antioxidation in Vitro of Ethanol Extract from Chaenomeles Speciosa (Sweet) Nakai,” Journal of China Three Gorges University (Natural Sciences), vol. 30, pp. 72–75, 2008.
View at: Google Scholar
M. Zhang, R. Zhao, S. Zhou et al., “Chemical characterization and evaluation of the antioxidants in Chaenomeles fruits by an improved HPLC-TOF/MS coupled to an on-line DPPH-HPLC method,” Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, vol. 36, no. 1, pp. 43–62, 2018.
View at: Publisher Site | Google Scholar
Q. Chen and W. Wei, “Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats,” International Immunopharmacology, vol. 3, no. 4, pp. 593–608, 2003.
View at: Publisher Site | Google Scholar
S. Li and Y. Chen, “Effect of Chaenomeles speciosa polysaccharide on adjuvant arthritis in mice and its mechanisms,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 17, pp. 159–162, 2011.
View at: Google Scholar
J. S. Kong and X. H. Yang, “Mechanisms analysis on the analgesic effect of total flavonoids extracted from Chaenomeles lagenaria,” Lishizhen Medicine and Materia Medica Research, vol. 20, pp. 549-550, 2009.
View at: Google Scholar
P. Schoenhagen, E. M. Tuzcu, and S. G. Ellis, “Plaque vulnerability, plaque rupture, and acute coronary syndromes: (Multi)-Focal manifestation of a Systemic disease process,” Circulation, vol. 106, no. 7, pp. 760–762, 2002.
View at: Publisher Site | Google Scholar
A. T. Borchers, J. S. Stern, R. M. Hackman, C. L. Keen, and M. E. Gershwin, “Mushrooms, Tumors, and Immunity,” Proceedings of the Society for Experimental Biology and Medicine, vol. 221, no. 4, pp. 281–293, 1999.
View at: Publisher Site | Google Scholar
X. Xie, G. Zou, and C. Li, “Antitumor and immunomodulatory activities of a water-soluble polysaccharide from Chaenomeles speciosa,” Carbohydrate Polymers, vol. 132, Article ID 10035, pp. 323–329, 2015.
View at: Publisher Site | Google Scholar
R. Wang, P. Chen, F. Jia, J. Tang, and F. Ma, “Optimization of polysaccharides from Panax japonicus C.A. Meyer by RSM and its anti-oxidant activity,” International Journal of Biological Macromolecules, vol. 50, no. 2, pp. 331–336, 2012.
View at: Publisher Site | Google Scholar
D. Zhang, S. Li, Q. Xiong, C. Jiang, and X. Lai, “Extraction, characterization and biological activities of polysaccharides from Amomum villosum,” Carbohydrate Polymers, vol. 95, no. 1, pp. 114–122, 2013.
View at: Publisher Site | Google Scholar
Z. Jin, “The extract of antitumor active ingredients in Chaenomeles speciosa,” Chin Tradit Herb Drug Commun, vol. 6, p. 18, 1975.
View at: Google Scholar
M. N. Laszczyk, “Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy,” Planta Medica, vol. 75, no. 15, pp. 1549–1560, 2009.
View at: Publisher Site | Google Scholar
G. Kuttan, P. Pratheeshkumar, K. A. Manu, and R. Kuttan, “Inhibition of tumor progression by naturally occurring terpenoids,” Pharmaceutical Biology, vol. 49, no. 10, pp. 995–1007, 2011.
View at: Publisher Site | Google Scholar
C.-C. Lin, C.-Y. Huang, M.-C. Mong, C.-Y. Chan, and M.-C. Yin, “Antiangiogenic potential of three triterpenic acids in human liver cancer cells,” Journal of Agricultural and Food Chemistry, vol. 59, no. 2, pp. 755–762, 2011.
View at: Publisher Site | Google Scholar
R. Chu, X. Zhao, C. Griffin et al., “Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid,” International Journal of Cancer, vol. 127, no. 5, pp. 1209–1219, 2010.
View at: Publisher Site | Google Scholar
R. Zhou, Z. Zhang, L. Zhao et al., “Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells,” Journal of Orthopaedic Research, vol. 29, no. 6, pp. 846–852, 2011.
View at: Publisher Site | Google Scholar
K. A. Lúcio, G. d. Rocha, L. C. Monção-Ribeiro et al., “Oleanolic Acid Initiates Apoptosis in Non-Small Cell Lung Cancer Cell Lines and Reduces Metastasis of a B16F10 Melanoma Model In Vivo,” PLoS ONE, vol. 6, no. 12, p. e28596, 2011.
View at: Publisher Site | Google Scholar
J.-C. Chen, Y.-S. Chang, S.-L. Wu et al., “Inhibition of Escherichia coli heat-labile enterotoxin-induced diarrhea by Chaenomeles speciosa,” Journal of Ethnopharmacology, vol. 113, no. 2, pp. 233–239, 2007.
View at: Publisher Site | Google Scholar
Q. Chen and W. Wei, “Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat,” International Immunopharmacology, vol. 2, no. 10, pp. 1443–1449, 2002.
View at: Publisher Site | Google Scholar
S. Jain, K. Akiyama, K. Mae, T. Ohguchi, and R. Takata, “Targeted disruption of a G protein α subunit gene results in reduced pathogenicity in Fusarium oxysporum,” Current Genetics, vol. 41, no. 6, pp. 407–413, 2002.
View at: Publisher Site | Google Scholar
M. A. Prado, B. Evans-Bain, and I. M. Dickerson, “Receptor component protein (RCP): A member of a multi-protein complex required for G-protein-coupled signal transduction,” Biochemical Society Transactions, vol. 30, no. 4, pp. 460–464, 2002.
View at: Publisher Site | Google Scholar
X. Zheng, H. Wang, P. Zhang et al., “Chemical Composition, Antioxidant Activity and α-Glucosidase Inhibitory Activity of Chaenomeles Speciosa from Four Production Areas in China,” Molecules, vol. 23, no. 10, p. 2518, 2018.
View at: Publisher Site | Google Scholar
F. Hiroyuki, Y. Tomohide, and O. Kazunori, “Efficacy and safety of Touchi extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus,” The Journal of Nutritional Biochemistry, vol. 12, no. 6, pp. 351–356, 2001.
View at: Publisher Site | Google Scholar
F. A. van de Laar, P. L. Lucassen, R. P. Akkermans, E. H. Van De Lisdonk, G. E. Rutten, and C. van Weel, “α-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis,” Diabetes Care, vol. 28, no. 1, pp. 154–163, 2005.
View at: Publisher Site | Google Scholar
H. Liu, J. Hu, L. Sun, Z. Cai, J. Shi, and T. Liu, “Inhibition effects of oleanolic acid from Chaenomeles lagenaria on hepatitis B virus in vitro,” Pharmaceutical Journal of Chinese People's Liberation Army, vol. 18, pp. 272–274, 2002.
View at: Google Scholar

Copyright

Copyright © 2018 Weifeng Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

3279

Downloads

1270

Citations